SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-21-005871
Filing Date
2021-08-12
Accepted
2021-08-12 10:56:38
Documents
59
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q acst20210630_10q.htm   iXBRL 10-Q 993041
2 EXHIBIT 31.1 ex_272984.htm EX-31.1 8322
3 EXHIBIT 31.2 ex_272985.htm EX-31.2 8287
4 EXHIBIT 32.1 ex_272986.htm EX-32.1 6054
5 EXHIBIT 32.2 ex_272987.htm EX-32.2 6217
  Complete submission text file 0001171843-21-005871.txt   4271199

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA acst-20210630.xsd EX-101.SCH 43082
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acst-20210630_cal.xml EX-101.CAL 27688
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acst-20210630_def.xml EX-101.DEF 256151
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE acst-20210630_lab.xml EX-101.LAB 215312
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acst-20210630_pre.xml EX-101.PRE 279651
11 EXTRACTED XBRL INSTANCE DOCUMENT acst20210630_10q_htm.xml XML 661390
Mailing Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5
Business Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5 450-686-4555
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-35776 | Film No.: 211166076
SIC: 2834 Pharmaceutical Preparations